[HTML][HTML] Galectin-3: one molecule for an alphabet of diseases, from A to Z

S Sciacchitano, L Lavra, A Morgante, A Ulivieri… - International journal of …, 2018 - mdpi.com
Galectin-3 (Gal-3) regulates basic cellular functions such as cell–cell and cell–matrix
interactions, growth, proliferation, differentiation, and inflammation. It is not surprising …

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies

G Musso, M Cassader, R Gambino - Nature reviews Drug discovery, 2016 - nature.com
Non-alcoholic fatty liver disease—the most common chronic liver disease—encompasses a
histological spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) …

[HTML][HTML] Galectin-3 activation and inhibition in heart failure and cardiovascular disease: an update

N Suthahar, WC Meijers, HHW Silljé, JE Ho, FT Liu… - Theranostics, 2018 - ncbi.nlm.nih.gov
Galectin-3 is a versatile protein orchestrating several physiological and pathophysiological
processes in the human body. In the last decade, considerable interest in galectin-3 has …

[HTML][HTML] Hematopoietic-derived galectin-3 causes cellular and systemic insulin resistance

P Li, S Liu, M Lu, G Bandyopadhyay, D Oh, T Imamura… - Cell, 2016 - cell.com
In obesity, macrophages and other immune cells accumulate in insulin target tissues,
promoting a chronic inflammatory state and insulin resistance. Galectin-3 (Gal3), a lectin …

[HTML][HTML] Intracellular galectin-3 is a lipopolysaccharide sensor that promotes glycolysis through mTORC1 activation

X Chen, C Yu, X Liu, B Liu, X Wu, J Wu, D Yan… - Nature …, 2022 - nature.com
How the carbohydrate binding protein galectin-3 might act as a diabetogenic and
tumorogenic factor remains to be investigated. Here we report that intracellular galectin-3 …

Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities

G Musso, M Cassader, S Cohney, F De Michieli… - Diabetes …, 2016 - Am Diabetes Assoc
Chronic kidney disease (CKD) is a risk factor for end-stage renal disease (ESRD) and
cardiovascular disease (CVD). ESRD or CVD develop in a substantial proportion of patients …

The role of galectins as modulators of metabolism and inflammation

MF Brinchmann, DM Patel… - Mediators of …, 2018 - Wiley Online Library
Galectins are β‐galcotosid‐binding lectins. The function of galectins varies with their tissue‐
specific and subcellular location, and their binding to carbohydrates makes them key players …

Adiponectin in inflammatory and immune-mediated diseases

G Fantuzzi - Cytokine, 2013 - Elsevier
Circulating levels of adiponectin (APN) are reduced in obesity and associated comorbidities,
with inflammation playing an important role in downregulating APN production. In contrast to …

[HTML][HTML] Antibiotic-induced alterations in gut microbiota are associated with changes in glucose metabolism in healthy mice

RR Rodrigues, RL Greer, X Dong, KN DSouza… - Frontiers in …, 2017 - frontiersin.org
The gut microbiome plays an important role in health and disease. Antibiotics are known to
alter gut microbiota, yet their effects on glucose tolerance in lean, normoglycemic mice have …

Krüppel-like factors: crippling and uncrippling metabolic pathways

NM Pollak, M Hoffman, IJ Goldberg… - JACC: Basic to …, 2018 - jacc.org
Krüppel-like factors (KLFs) are deoxyribonucleic acid–binding transcriptional factors that
regulate various pathways that control metabolism and other cellular mechanisms. Various …